Can you take Mounjaro or Zepbound if you take birth control?
LAST UPDATED: Nov 29, 2023
1 MIN READ
HERE'S WHAT WE'LL COVER
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
Fad diets stop here
If appropriate, get effective weight loss treatment prescribed for your body.
Can you take Mounjaro or Zepbound if you use birth control pills?
Birth control pills, also called oral contraceptives, are the most common type of birth control used by women today. And as the popularity of medications like Mounjaro and Zepbound (tirzepatide) for weight loss and diabetes management increases, many people are asking if they can continue their regular birth control regimen on their new medications. The short answer: tirzepatide (the active ingredient in Mounjaro and Zepbound) can interfere with oral contraceptives. That’s because tirzepatide works in part by slowing down the passage of contents through your digestive system, and this delayed gastric emptying has been shown to make some medications taken by mouth––like oral contraceptives––less effective.
The decrease in oral contraception’s effectiveness is strongest whenever you start a new Zepbound dose and improves over time. If you’re considering starting treatment with tirzepatide, inform your provider about which contraception you’re taking.
If you are treated with tirzepatide and use an oral contraception method, the drug’s manufacturer recommends the following:
For the first four weeks after first starting Zepbound and for the first four weeks after each dose escalation, continue using your oral contraception and add a barrier method of contraception (such as condoms) to prevent pregnancy. Alternatively, you can switch to a non-oral contraceptive method (such as an IUD or implant) before starting your medication.
For more complete information about Zepbound, see full Important Safety Information.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
U.S. Food and Drug Administration (FDA). (2022). Highlights of prescribing information. MOUNJARO™ (tirzepatide) Injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf